#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroid melanoma Non-Hodgkin's lymphoma Mitochondrial encephalomyopathy Richter's syndrome Friedreich's ataxia Penile squamous cell carcinoma Parkinson's disease Deafness Pulmonary alveolar haemorrhage Intracranial calcification Nephrotic syndrome Stargardt's disease Medullary thyroid cancer Pelizaeus-Merzbacher disease Palmoplantar pustulosis More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Life with Disease Pituitary-dependent Cushing’s syndrome Wiskott-Aldrich syndrome Mucopolysaccharidosis III – Treatment Systemic sclerosis pulmonary – Treatment Angiosarcoma metastatic – Life with Disease Thrombotic thrombocytopenic purpura – Treatment Factor VIII deficiency Nodal marginal zone B-cell lymphoma – Diagnostics Cystic fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DISODIUM PHOSPHATE Lucerastat Bromocriptine L-ALANINE Allogeneic Faecal Microbiota Diltiazem Hydrochloride Alpelisib Domperidone Sertraline Hydrochloride Gad20-209-Fsp-A2 Secukinumab Benzylpenicillin Zenocutuzumab Heparin Calcium Elenestinib Phosphate Osteodex Ivospemin Ixazomib Anifrolumab BUMETANIDE More therapies…

    Learn about Your Condition

    Nasal sinus cancer Glucose tolerance impaired Small intestine carcinoma Tonsillitis Bipolar disorder Laryngeal leukoplakia Bacterial prostatitis Cholecystitis acute Acute promyelocytic leukaemia Periarthritis Thrombosis Colorectal cancer stage II Inclusion body myositis Choroidal dystrophy Haemorrhage prophylaxis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Carfilzomib
    • Dexamethasone Sodium Phosphate
    Austria Belgium Czechia Denmark Finland France +11

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7

  • Study on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Emtricitabine
    • Entecavir
    • Ianalumab
    Czechia France Hungary Lithuania Romania Spain

  • Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Ivabradine Hydrochloride
    Italy

  • Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Inclisiran
    Austria Belgium Czechia France Germany Greece +6

  • Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

    Recruiting

    3 1
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Finland France Germany Italy +5
Previous Page
1 … 648 649 650 651 652 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!